ACADIA
Live / Registered — Registered (as of 05 Apr 2022)
What this means for you
Registered since 05 Apr 2022. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 90081737
- Registration number
- 6695065
- Mark type
- Design + words
- Filed
- 29 Jul 2020
- Published for opposition
- 22 Dec 2020
- Registered
- 05 Apr 2022
- Attorney of record
- Brian Focarino
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceuticals for use in the prevention and treatment of neurologic, metabolic, genetic, psychologic and psychiatric diseases and disorders
- Class 042 — Scientific and technological services: Scientific and industrial biotechnological and biomedical research; chemical, biochemical and molecular biological analyses; medical testing, namely, in vitro and in vivo preclinical testing of potential drugs; consultation related thereto
Owner
- ACADIA Pharmaceuticals, Inc., San Diego, CA, US
- ACADIA Pharmaceuticals, Inc., San Diego, CA, US
- ACADIA Pharmaceuticals, Inc., San Diego, CA, US
Prior registrations
Prosecution history
- 12 Jun 2024 — TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
- 12 Jun 2024 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 12 Jun 2024 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 12 Jun 2024 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 05 Apr 2022 — REGISTERED-PRINCIPAL REGISTER
- 01 Mar 2022 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 28 Feb 2022 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 23 Feb 2022 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 22 Feb 2022 — STATEMENT OF USE PROCESSING COMPLETE
- 15 Feb 2022 — USE AMENDMENT FILED
- 22 Feb 2022 — SOU EXTENSION 2 GRANTED
- 15 Feb 2022 — SOU EXTENSION 2 FILED
- 22 Feb 2022 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 15 Feb 2022 — SOU TEAS EXTENSION RECEIVED
- 15 Feb 2022 — TEAS STATEMENT OF USE RECEIVED